SARAH HUTCHERSON: Open Payments
NPI 1932351897 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,807 in 121 payments from 27 companies in 2025. Trend: 2023 $1,069 · 2024 $1,443 · 2025 $1,807
Food & beverage: $1,807
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $586 |
| Vanda Pharmaceuticals Inc. | 27 | $197 |
| PFIZER INC. | 9 | $151 |
| GENZYME CORPORATION | 3 | $85 |
| Intra-Sana Laboratories | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| UCB, Inc. | 2 | $58 |
| Lilly USA, LLC | 3 | $56 |
| Lundbeck LLC | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
Products named: VRAYLAR, SKYRIZI, FANAPT, DUPIXENT, REXULTI, NURTEC ODT, PREVNAR 20, RELTONE 200 MG.
Industry payments across OK — which companies pay providers there.
